NO901122L - Reagens for paavisning av droger. - Google Patents

Reagens for paavisning av droger.

Info

Publication number: NO901122L
Authority: NO; Norway
Prior art keywords: drug; reagent; reagents; drug detection; detection
Prior art date: 1989-03-10

Application number

NO90901122A

Other languages

English (en)

Other versions

NO901122D0 (no

NO178007B (no

NO178007C (no

Inventor

Salvatore Joseph Salamone

Stephen Vitone

Original Assignee

Hoffmann La Roche

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1989-03-10

Filing date

1990-03-09

Publication date

1990-09-11

1990-03-09 Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche

1990-03-09 Publication of NO901122D0 publication Critical patent/NO901122D0/no

1990-09-11 Publication of NO901122L publication Critical patent/NO901122L/no

1995-09-25 Publication of NO178007B publication Critical patent/NO178007B/no

1996-01-03 Publication of NO178007C publication Critical patent/NO178007C/no

Links

239000003153 chemical reaction reagent Substances 0.000 title abstract 3
239000003814 drug Substances 0.000 title abstract 3
229940079593 drug Drugs 0.000 title abstract 3
238000001514 detection method Methods 0.000 title abstract 2
NQTADLQHYWFPDB-UHFFFAOYSA-N N-Hydroxysuccinimide Chemical compound ON1C(=O)CCC1=O NQTADLQHYWFPDB-UHFFFAOYSA-N 0.000 abstract 1
230000003213 activating effect Effects 0.000 abstract 1
210000001124 body fluid Anatomy 0.000 abstract 1
239000010839 body fluid Substances 0.000 abstract 1
239000003118 drug derivative Substances 0.000 abstract 1
239000002359 drug metabolite Substances 0.000 abstract 1
238000003018 immunoassay Methods 0.000 abstract 1
150000002540 isothiocyanates Chemical class 0.000 abstract 1
125000005647 linker group Chemical group 0.000 abstract 1
-1 poly(amino acid) Polymers 0.000 abstract 1
229920001308 poly(aminoacid) Polymers 0.000 abstract 1
229920000642 polymer Polymers 0.000 abstract 1

Classifications

- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54353—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals with ligand attached to the carrier via a chemical coupling agent
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/815—Test for named compound or class of compounds
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/815—Test for named compound or class of compounds
- Y10S436/816—Alkaloids, amphetamines, and barbiturates
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/807—Hapten conjugated with peptide or protein
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/81—Carrier - bound or immobilized peptides or proteins and the preparation thereof, e.g. biological cell or cell fragment as carrier
- Y10S530/812—Peptides or proteins is immobilized on, or in, an organic carrier
- Y10S530/815—Carrier is a synthetic polymer
- Y10S530/816—Attached to the carrier via a bridging agent

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Immunology (AREA)
Engineering & Computer Science (AREA)
Molecular Biology (AREA)
Biomedical Technology (AREA)
Chemical & Material Sciences (AREA)
Hematology (AREA)
Urology & Nephrology (AREA)
Biochemistry (AREA)
Microbiology (AREA)
Cell Biology (AREA)
Food Science & Technology (AREA)
Medicinal Chemistry (AREA)
Physics & Mathematics (AREA)
Analytical Chemistry (AREA)
Biotechnology (AREA)
General Health & Medical Sciences (AREA)
General Physics & Mathematics (AREA)
Pathology (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Investigating Or Analysing Biological Materials (AREA)
Pyrrole Compounds (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
Plural Heterocyclic Compounds (AREA)
Medicinal Preparation (AREA)
Peptides Or Proteins (AREA)
Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

NO901122A 1989-03-10 1990-03-09 Reagens for påvisning av droger NO178007C (no)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US32194689A	1989-03-10	1989-03-10

Publications (4)

Publication Number	Publication Date
NO901122D0 NO901122D0 (no)	1990-03-09
NO901122L true NO901122L (no)	1990-09-11
NO178007B NO178007B (no)	1995-09-25
NO178007C NO178007C (no)	1996-01-03

Family

ID=23252745

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO901122A NO178007C (no)	1989-03-10	1990-03-09	Reagens for påvisning av droger

Country Status (12)

Country	Link
US (1)	US5618926A (no)
EP (1)	EP0386644B1 (no)
JP (1)	JP3009170B2 (no)
AT (1)	ATE154135T1 (no)
AU (1)	AU624686B2 (no)
CA (1)	CA2011722C (no)
DE (1)	DE69030829T2 (no)
DK (1)	DK0386644T3 (no)
ES (1)	ES2104566T3 (no)
NO (1)	NO178007C (no)
NZ (1)	NZ232854A (no)
ZA (1)	ZA901808B (no)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5155212A (en) *	1986-05-21	1992-10-13	Abbott Laboratories	Phencyclidine and phencyclidine metabolites assay, tracers, immunogens, antibodies and reagent kit
US5612034A (en) *	1990-10-03	1997-03-18	Redcell, Inc.	Super-globuling for in vivo extended lifetimes
ATE140795T1 (de) *	1990-10-22	1996-08-15	Abbott Lab	Homobifunktionelle agenzien zur kupplung von enzymen un deren analogen an antikörper und deren analoge
US5284948A (en) *	1991-06-07	1994-02-08	Eastman Kodak Company	Drug hapten analogues for immunoassays
DE69232002T2 (de) *	1991-06-07	2002-06-06	Johnson & Johnson Clinical Diagnostics, Inc.	Immunoassays unter Verwendung von markierten Hapten-Analogen
US5304479A (en) *	1991-12-06	1994-04-19	Diagnostic Reagents, Inc.	Phencyclidine compounds and assays for its determination
US5302715A (en) *	1992-04-06	1994-04-12	Biosite Diagnostics, Inc.	Benzodiazepine derivatives
CA2096495C (en) *	1992-06-16	2002-07-09	Kathy Palmer Ordonez	Dual analyte immunoassay
US6090925A (en)	1993-03-09	2000-07-18	Epic Therapeutics, Inc.	Macromolecular microparticles and methods of production and use
US5981719A (en)	1993-03-09	1999-11-09	Epic Therapeutics, Inc.	Macromolecular microparticles and methods of production and use
CA2167362A1 (en) *	1995-02-10	1996-08-11	Alexei Dmitri Klimov	Apparatus and method for conducting a binding assay on an absorbent carrier material
US5840307A (en) *	1995-03-31	1998-11-24	Immulogic Pharmacuetical Corp.	Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation
ATE254930T1 (de) *	1995-03-31	2003-12-15	Xenova Res Ltd	Hapten-träger-konjugate zur anwendung in der drogen-missbrauchs-therapie
DE19630102A1 (de) *	1996-07-25	1998-01-29	Boehringer Mannheim Gmbh	Neue aktivierte Amphetamine
US6558956B1 (en) *	1997-06-24	2003-05-06	The University Of Wyoming	Method and apparatus for detection of a controlled substance
US6770488B1 (en)	1999-03-19	2004-08-03	The University Of Wyoming	Practical method and apparatus for analyte detection with colloidal particles
US6262265B1 (en) *	1999-06-18	2001-07-17	Microgenics Corporation	Non-hydrolyzable analogs of heroin metabolites suitable for use in immunoassay
US6811998B2 (en)	1999-06-25	2004-11-02	Roche Diagnostics Operations, Inc.	Conjugates of uncompetitive inhibitors of inosine monophosphate dehydrogenase
US6664061B2 (en)	1999-06-25	2003-12-16	Amersham Biosciences Ab	Use and evaluation of a [2+2] photoaddition in immobilization of oligonucleotides on a three-dimensional hydrogel matrix
US6921638B2 (en)	1999-06-25	2005-07-26	Amersham Biosciences Ab	Hydrogel-based microarray signal amplification methods and devices therefor
US6372813B1 (en)	1999-06-25	2002-04-16	Motorola	Methods and compositions for attachment of biomolecules to solid supports, hydrogels, and hydrogel arrays
GB2361473C (en) *	2000-03-08	2005-06-28	Microgenics Corp	Ecstasy-class analogs and use of same in detection of ecstasy-class compounds
US6534325B1 (en)	2000-06-30	2003-03-18	Roche Diagnostics Corporation	Immunoassay for the detection of amphetamines, methamphetamines and methylenedioxy designer amphetamines
US8394813B2 (en)	2000-11-14	2013-03-12	Shire Llc	Active agent delivery systems and methods for protecting and administering active agents
AU2002241602A1 (en) *	2000-11-16	2002-06-11	Burstein Technologies, Inc.	Methods and apparatus for detecting and quantifying lymphocytes with optical biodiscs
US6472228B2 (en)	2000-12-04	2002-10-29	Lifepoint, Inc.	Composition and methods for synthesis of novel tracers for detecting amphetamine and methamphetamine in samples
US6368814B1 (en) *	2000-12-22	2002-04-09	Roche Diagnostics Corporation	Tricyclic antidepressant derivatives and immunoassay
US7141416B2 (en) *	2001-07-12	2006-11-28	Burstein Technologies, Inc.	Multi-purpose optical analysis optical bio-disc for conducting assays and various reporting agents for use therewith
US7169752B2 (en) *	2003-09-30	2007-01-30	New River Pharmaceuticals Inc.	Compounds and compositions for prevention of overdose of oxycodone
US20060014697A1 (en) *	2001-08-22	2006-01-19	Travis Mickle	Pharmaceutical compositions for prevention of overdose or abuse
US20030143637A1 (en) *	2001-08-31	2003-07-31	Selvan Gowri Pyapali	Capture layer assemblies for cellular assays including related optical analysis discs and methods
CN1659439A (zh) *	2001-09-07	2005-08-24	伯斯坦技术公司	利用光学生物盘系统基于细胞核形态学的白血细胞类型的识别和定量
EP2236161A1 (en)	2001-10-18	2010-10-06	Nektar Therapeutics	Polymer conjugates of opioid antagonists
CA2468041A1 (en) *	2001-11-20	2003-05-30	Burstein Technologies, Inc.	Optical bio-discs and microfluidic devices for analysis of cells
US20050003459A1 (en) *	2002-01-30	2005-01-06	Krutzik Siegfried Richard	Multi-purpose optical analysis disc for conducting assays and related methods for attaching capture agents
US6858672B2 (en) *	2002-06-20	2005-02-22	Basell Poliolefine Italia S.P.A.	Safe process for making polymers containing N-phenylimide groups
ES2392170T3 (es)	2003-07-01	2012-12-05	F. Hoffmann-La Roche Ag	Sistema de biosensor de afinidad electroquímica y métodos de utilización
US7060847B2 (en) *	2003-07-18	2006-06-13	Roche Diagnostics Operations, Inc.	Ecstasy-class derivatives, immunogens, and antibodies and their use in detecting ecstasy-class drugs
HRP20140361T1 (hr) *	2003-12-16	2014-05-23	Nektar Therapeutics	Monodisperzne smjese pegiliranog naloksola
US20060182692A1 (en) *	2003-12-16	2006-08-17	Fishburn C S	Chemically modified small molecules
US7220842B2 (en) *	2004-04-05	2007-05-22	Dade Behring Inc.	Immunoassays for buprenorphine and norbuprenorphine
US20060024748A1 (en) *	2004-07-29	2006-02-02	Saladax Biomedical Inc.	Cytoxan antibodies and immunoassay
US7238791B1 (en) *	2005-12-16	2007-07-03	Roche Diagnostics Operations, Inc.	6-monoacetylmorphine derivatives useful in immunoassay
CN106442961B (zh) *	2007-07-26	2018-08-14	埃葛梅崔克斯股份有限公司	电化学分析物检测装置和方法
US8133743B2 (en) *	2007-10-19	2012-03-13	Roche Diagnostics Operations, Inc.	Phenobarbital derivatives useful in immunoassay
US8409807B2 (en)	2010-10-22	2013-04-02	T2 Biosystems, Inc.	NMR systems and methods for the rapid detection of analytes
US8563298B2 (en)	2010-10-22	2013-10-22	T2 Biosystems, Inc.	NMR systems and methods for the rapid detection of analytes
CA2815085C (en)	2010-10-22	2022-06-21	T2 Biosystems, Inc.	Nmr systems and methods for the rapid detection of analytes
CN102621296A (zh) *	2012-01-06	2012-08-01	天津医科大学	一种带有间隔臂的羧化聚苯乙烯微球上偶联蛋白质的方法
WO2013158281A1 (en)	2012-04-20	2013-10-24	T2 Biosystems, Inc.	Compositions and methods for detection of candida species
AU2017210033B2 (en)	2016-01-21	2022-09-29	T2 Biosystems, Inc.	NMR methods and systems for the rapid detection of bacteria

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3917582A (en) *	1973-06-13	1975-11-04	Syva Corp	Isothiocyanate and thiourea derivatives of benzoyl ecgonine conjugated to polypeptides
US3888864A (en) *	1973-06-29	1975-06-10	Hoffmann La Roche	Amino lower alkyl ether derivatives of opium alkaloids
US4101549A (en) *	1976-05-26	1978-07-18	Hoffmann-La Roche Inc.	Aminophenyl esters of 5-carboxyalkyl barbituric acids
US4340736A (en) *	1976-05-26	1982-07-20	Hoffmann-La Roche Inc.	Diagnostic test for barbiturates
IL49685A (en) *	1976-05-31	1978-10-31	Technion Res & Dev Foundation	Specific binding assay method for determining the concentration of materials and reagent means therefor
US4196185A (en) *	1978-06-05	1980-04-01	Hoffmann-La Roche Inc.	Immunoassay for phencyclidine
US4223013A (en) *	1978-12-29	1980-09-16	Syva Company	Amitriptyline conjugates to antigenic proteins and enzymes
US4275160A (en) *	1979-07-06	1981-06-23	Syva Company	Imipramine derivatives and poly(amino acid) conjugates
US4318846A (en) *	1979-09-07	1982-03-09	Syva Company	Novel ether substituted fluorescein polyamino acid compounds as fluorescers and quenchers
US4351760A (en) *	1979-09-07	1982-09-28	Syva Company	Novel alkyl substituted fluorescent compounds and polyamino acid conjugates
US4262089A (en) *	1980-04-07	1981-04-14	Syva Company	Theophylline antigens and antibodies
EP0045334B1 (en) *	1980-08-04	1984-03-14	Syva Company	Propranolol antigen conjugates and antibodies and method of using them
US4366241A (en) *	1980-08-07	1982-12-28	Syva Company	Concentrating zone method in heterogeneous immunoassays
US4401765A (en) *	1981-09-01	1983-08-30	E. I. Du Pont De Nemours And Company	Covalently bonded high refractive index particle reagents and their use in light scattering immunoassays
US4424150A (en) *	1982-04-02	1984-01-03	Syva Company	Acetaminophen analogs, antigens, and antibodies
DE3382795T2 (de) *	1982-05-18	1996-02-15	University Of Florida, Gainesville, Fla.	Gehirnspezifische arzneimittelabgabe.
US4629691A (en) *	1983-08-01	1986-12-16	Syntex (U.S.A.) Inc.	Tricyclic antidepressant conjugates with antigens and enzymes
US4820834A (en) *	1984-06-26	1989-04-11	Merck & Co., Inc.	Benzodiazepine analogs
CA1332410C (en) *	1984-06-26	1994-10-11	Roger M. Freidinger	Benzodiazepine analogs
EP0199042A1 (en) *	1985-03-26	1986-10-29	Abbott Laboratories	Procainamide assay, tracers, immunogens and antibodies
US4680338A (en) *	1985-10-17	1987-07-14	Immunomedics, Inc.	Bifunctional linker
ES2093601T3 (es) *	1987-02-17	1997-01-01	Abbott Lab	Inmunoensayo de polarizacion de fluorescencia para tetrahidrocannabinoides.
US4791067A (en) *	1987-06-25	1988-12-13	Fisher Scientific Co.	Agglutination immunoassay for hapten involving monoclonal antibody of IgA class reagent

1990
- 1990-03-02 DE DE69030829T patent/DE69030829T2/de not_active Expired - Lifetime
- 1990-03-02 DK DK90104055.0T patent/DK0386644T3/da active
- 1990-03-02 AT AT90104055T patent/ATE154135T1/de not_active IP Right Cessation
- 1990-03-02 ES ES90104055T patent/ES2104566T3/es not_active Expired - Lifetime
- 1990-03-02 EP EP90104055A patent/EP0386644B1/en not_active Expired - Lifetime
- 1990-03-08 ZA ZA901808A patent/ZA901808B/xx unknown
- 1990-03-08 NZ NZ232854A patent/NZ232854A/en unknown
- 1990-03-08 CA CA002011722A patent/CA2011722C/en not_active Expired - Lifetime
- 1990-03-09 NO NO901122A patent/NO178007C/no not_active IP Right Cessation
- 1990-03-09 JP JP2056817A patent/JP3009170B2/ja not_active Expired - Lifetime
- 1990-03-09 AU AU51231/90A patent/AU624686B2/en not_active Ceased
1994
- 1994-05-26 US US08/249,676 patent/US5618926A/en not_active Expired - Lifetime

Also Published As

Publication number	Publication date
CA2011722A1 (en)	1990-09-10
US5618926A (en)	1997-04-08
NO901122D0 (no)	1990-03-09
NO178007B (no)	1995-09-25
CA2011722C (en)	2001-06-19
EP0386644A3 (en)	1992-10-07
EP0386644B1 (en)	1997-06-04
EP0386644A2 (en)	1990-09-12
JPH03200763A (ja)	1991-09-02
ATE154135T1 (de)	1997-06-15
JP3009170B2 (ja)	2000-02-14
ZA901808B (en)	1990-12-28
DE69030829T2 (de)	1998-01-15
NO178007C (no)	1996-01-03
DK0386644T3 (da)	1997-10-13
AU624686B2 (en)	1992-06-18
NZ232854A (en)	1993-03-26
AU5123190A (en)	1990-11-22
DE69030829D1 (de)	1997-07-10
ES2104566T3 (es)	1997-10-16

Legal Events

Date	Code	Title	Description
2004-12-27	MM1K	Lapsed by not paying the annual fees

Publication	Publication Date	Title
NO178007C (no)	1996-01-03	Reagens for påvisning av droger
US4444879A (en)	1984-04-24	Immunoassay with article having support film and immunological counterpart of analyte
EP0399184B1 (en)	1995-09-13	Reagents, methods and kits for an amphetamine-class fluorescence polarization immunoassay
EP0406473B1 (en)	1995-09-20	Ion capture reagents and methods for performing binding assays
EP0077671B1 (en)	1986-06-25	Immunological reagents employing polymeric backbones
Peng et al.	1977	High-pressure liquid-chromatographic method for determination of gentamicin in plasma.
CA1303495C (en)	1992-06-16	Use of immobilized biotinylated receptor in test device, kit and method for determining a ligand
FI905614A0 (fi)	1990-11-13	Diagnostisering och behandling av insulinberoende sockersjuka.
FI102921B (fi)	1999-03-15	Menetelmä biologisesti aktiivisten reagenssien valmistamiseksi sukkiin i-imidiä sisältävistä polymeereistä, analyysielementti ja menetelmiä n iiden käyttämiseksi
DE3145082A1 (de)	1983-05-19	"ein latex, biologisch aktive latexkonjugate und verfahren zu ihrer herstellung"
ATE97496T1 (de)	1993-12-15	Verfahren zum nachweis spezifisch bindefaehiger substanzen in koerperfluessigkeiten.
ATE135052T1 (de)	1996-03-15	Zusammensetzung und verfahren zur bestimmung von ketonkörpern
KR910005862A (ko)	1991-04-27	신규 친수성 유도체, 진단 또는 치료시 그의 응용 그를 함유하는 진단 또는 치료용 키트 및 면역 시약
GB1595101A (en)	1981-08-05	Enzyme modifier immunoassay
US5208166A (en)	1993-05-04	Reactive chitosan coated articles and test kit for immunoassay
DE69530512T2 (de)	2004-03-25	Phosphatase-aktivierte quervernetzende konjugierende und reduzierende agenzien, verfahren unter verwendung solcher agenzien und reagenzien die phosphatase-aktivierte quervernetzende und konjugierende agenzien enthalten
CA2071173C (en)	1999-05-25	B12 enzyme immunoassay and sample pretreatment
US20040146500A1 (en)	2004-07-29	Biopolymer-containing gel
WO1987004794A1 (en)	1987-08-13	Latex agglutination using avidin/biotin system
CA1321998C (en)	1993-09-07	Tracers for use in flecainide fluorescence polarization immunoassay
ATE143142T1 (de)	1996-10-15	Immunoassay zum nachweis von antikörpern gegen hiv
ATE97497T1 (de)	1993-12-15	Verfahren zur untersuchung von antikoerpern spezifisch fuer rheumakrankheiten, insbesondere chronische polyarthritis sowie reagens hierfuer.
SU1529086A1 (ru)	1989-12-15	Способ количественного определени новокаина
JP3655657B2 (ja)	2005-06-02	アッセイ試薬及びそれを使用した測定方法
Juaristi	1983	Immunoassay in therapeutic drug monitoring